Long-Term safety and performance of the IntraSPINE interlaminar implant for degenerative lumbar spine disease
Official title: Long-Term Evaluation of the Performance and Safety of the IntraSPINE® Interlaminar Implant in the Treatment of Lumbar Degenerative Disc Disease
Run by Cousin Biotech · NCT07790328 · Data updated 2026-11-12
This study follows up patients who previously received IntraSPINE implants to see how their symptoms and imaging look about 9 years later.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Cousin Biotech Industry-sponsored |
| Locations | 1 site (Saran) |
| Status | Recruiting |
| Started | July 28, 2020 |
| Main results expected | June 1, 2026 |
| Study ends | June 1, 2031 |
| Registry record updated | August 27, 2026 |
| Trial ID | NCT07790328 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with degenerative lumbar disc disease at one or two levels who were indicated for IntraSPINE implantation after conservative treatment failed.
✕Probably not a fit
Patients whose condition does not improve or worsens over time or those with contraindications may derive no clear benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational extension study tracking patients who had the IntraSPINE implant for degenerative lumbar spine conditions. It recontacts about 50 participants from an earlier trial (2012–2017) to collect long-term clinical and radiological data, including MRI findings. The goal is to understand long-term safety and performance of the implant in real-world follow-up. Participants are adults who had one or two lumbar levels treated after conservative care failed, with assessment ongoing at least 9 years post-implant. The study design does not assign treatment randomized groups and focuses on extended observation.
Why it matters
Potential benefit: If successful, results could clarify long-term safety and durability of the IntraSPINE implant for chronic lumbar spine conditions.
How similar studies have gone: Previous prospective work suggests potential for implant-based approaches, with long-term follow-up remaining limited and this study adds real-world extension data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patient, * Patient with degenerative lumbar disc disease at one or two levels for whom * Surgery involving the placement of an IntraSPINE® implant has been indicated following the failure of conservative treatment, * Patient who has read and signed the information and consent form Exclusion Criteria: * Patients with the following contraindications: * Allergy to any of the components, * Infected site, * Pregnant women. * Patients with spondylolisthesis with isthmic lysis
Where it's running
-
Maison des consultations
Saran, France Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-guided Pharmacopuncture for Spinal Pain in Korea
This registry follows patients with spinal pain to see if ultrasound-guided pharmacopuncture is safe and helps reduce pain.
-
Pressure-guided limited bone removal versus standard laminectomy for symptomatic lumbar spinal stenosis
This test will see if using epidural pressure to guide a smaller bone removal works as well as standard open laminectomy for people with symptomatic lumbar spinal stenosis.
-
Fecal microbiota transplantation for treating axial spondyloarthritis
This study is testing if a treatment using gut bacteria from healthy donors can help people with axial spondyloarthritis who aren't feeling better with their current medications.
-
Analyzing how degenerative spinal disease affects walking
This study looks at how degenerative spinal disease affects walking in people to see what changes happen as the disease progresses and with treatment.
-
Advanced spinal radiation therapy using MR imaging
This study is testing a new type of radiation therapy for spinal tumors that uses advanced imaging to see if it can better control the disease and improve patients' quality of life.
-
Gene expression profiles in spinal tuberculosis
This study is trying to see if different gene patterns in spinal tuberculosis can help doctors better understand and treat the disease, especially in people with HIV.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.